Abstract
With increased numbers of screening examinations and awareness of women regarding suspicious clinical findings, the number of lesions requiring further assessment increases. In addition, the average size of a detected lesion decreases, and reliable imaging modalities for guiding further procedures are required.
After the successful detection of a lesion of concern in various modalities for breast imaging like US, MRI, mammography, tomosynthesis, or contrast-enhanced mammography, a histological proof of the nature of this lesion is necessary.
As open surgical biopsy has been the method of choice in former days, minimally invasive procedures have come into focus and are recommended now for providing histological proof and information for operative or neoadjuvant therapy planning (Wallis et al., Eur Radiol 17(2):581–588, 2007; Perry et al., European guidelines for quality assurance in breast cancer screening and diagnosis, 2006; Helbich et al., Eur Radiol 14(3):383–393, 2004; Bick et al., Insights Imaging 11(1):12, 2020).
Due to different approaches in the treatment of breast cancer, surgery is no longer always the first line of treatment. Preoperative minimally invasive assessment of a carcinoma is requested to get further information about the molecular subtype of a lesion in order to tailor treatment and avoid unnecessary damage and scarring, or further anxiety due to additional general anesthesia (Wallis et al., Eur Radiol 17(2):581–588, 2007; Perry et al., European guidelines for quality assurance in breast cancer screening and diagnosis, 2006).
Additionally, minimally invasive approaches are less expensive and are performed in an outpatient setting (Gruber et al., Eur J Radiol 74(3):519–524, 2010; Abbate et al. Breast 18(2):73–77, 2009).
Ultrasound is a cheap and widely available technique, in addition it is quite comfortable for women and therefore the working horse in the field of breast biopsies. Furthermore, it plays a major role in preoperative localization of non-palpable lesions and is used more and more often to guide vacuum-assisted removal of benign lesions and other tumor ablation techniques.
In this chapter, we explain how to manage ultrasound-guided interventions and provide tips and tricks to successfully plan and perform ultrasound-guided procedures.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Abbate F et al (2009) Ultrasound-guided vacuum assisted breast biopsy in the assessment of C3 breast lesions by ultrasound-guided fine needle aspiration cytology: results and costs in comparison with surgery. Breast 18(2):73–77
Ahn HS et al (2016) Diagnosis of columnar cell lesions and atypical ductal hyperplasia by ultrasound-guided core biopsy: findings associated with underestimation of breast carcinoma. Ultrasound Med Biol 42(7):1457–1463
Altobelli E, Lattanzi A (2014) Breast cancer in European Union: an update of screening programmes as of March 2014 (review). Int J Oncol 45(5):1785–1792
Association of Breast Surgery at Baso (2009) Surgical guidelines for the management of breast cancer. Eur J Surg Oncol 35(Suppl 1):1–22
Atkins KA et al (2013) Atypical lobular hyperplasia and lobular carcinoma in situ at core breast biopsy: use of careful radiologic-pathologic correlation to recommend excision or observation. Radiology 269(2):340–347
Bae S et al (2015) Breast microcalcifications: diagnostic outcomes according to image-guided biopsy method. Korean J Radiol 16(5):996–1005
Bick U et al (2020) Image-guided breast biopsy and localisation: recommendations for information to women and referring physicians by the European Society of Breast Imaging. Insights Imaging 11(1):12
Charles M et al (2003) Effect of stereotactic core needle biopsy on pathologic measurement of tumor size of T1 invasive breast carcinomas presenting as mammographic masses. Cancer 97(9):2137–2141
Cho N et al (2009) Ultrasound-guided vacuum-assisted biopsy of microcalcifications detected at screening mammography. Acta Radiol 50(6):602–609
Ellis IO et al (2004) Best Practice No 179. Guidelines for breast needle core biopsy handling and reporting in breast screening assessment. J Clin Pathol 57:897–902
European Society of Radiology (2011) White paper on radiation protection by the European Society of Radiology. Insights Imaging 2(4):357–362
Evans A et al (2018) Breast ultrasound: recommendations for information to women and referring physicians by the European Society of Breast Imaging. Insights Imaging 9(4):449–461
Greenwood HI et al (2017) Clustered microcysts on breast ultrasound: what is an appropriate management recommendation? AJR Am J Roentgenol 209(6):W395–W399
Gruber R, Walter E, Helbich TH (2010) Cost comparison between ultrasound-guided 14-g large core breast biopsy and open surgical biopsy: an analysis for Austria. Eur J Radiol 74(3):519–524
Hahn M et al (2012) Interdisciplinary consensus recommendations for the use of vacuum-assisted breast biopsy under sonographic guidance: first update 2012. Ultraschall Med 33(4):366–371
Helbich TH, Matzek W, Fuchsjager MH (2004) Stereotactic and ultrasound-guided breast biopsy. Eur Radiol 14(3):383–393
Huang ML et al (2017) Comparison of the accuracy of US-guided biopsy of breast masses performed with 14-gauge, 16-gauge and 18-gauge automated cutting needle biopsy devices, and review of the literature. Eur Radiol 27:2928–2933
Humphrey KL et al (2014) Percutaneous breast biopsy: effect on short-term quality of life. Radiology 270(2):362–368
Jaffe TA et al (2015) Management of anticoagulant and antiplatelet medications in adults undergoing percutaneous interventions. AJR Am J Roentgenol 205(2):421–428
Jang M et al (2008) Underestimation of atypical ductal hyperplasia at sonographically guided core biopsy of the breast. AJR Am J Roentgenol 191:1347–1351
Jung HK et al (2014) Benign core biopsy of probably benign breast lesions 2 cm or larger: correlation with excisional biopsy and long-term follow-up. Ultrasonography 33:200–205
Jung I et al (2018) Ultrasonography-guided 14-gauge core biopsy of the breast: results of 7 years of experience. Ultrasonography 37:55–62
Kim HS et al (2008) US-guided vacuum-assisted biopsy of microcalcifications in breast lesions and long-term follow-up results. Korean J Radiol 9(6):503–509
Kricheldorff J et al (2018) Breast implant-associated lymphoma. Dtsch Arztebl Int 115(38):628–635
Lai HW et al (2013) Differences in accuracy and underestimation rates for 14- versus 16-gauge core needle biopsies in ultrasound-detectable breast lesions. Asian J Surg 36(2):83–88
Lee AHS, Anderson N et al (2016) Guidelines for non-operative diagnostic procedures and reporting in breast cancer screening. Royal College of Pathologists, London
Lee AY et al (2018) Sonographic-MRI correlation after percutaneous sampling of targeted breast ultrasound lesions: initial experiences with limited-sequence unenhanced MRI for postprocedural clip localization. AJR Am J Roentgenol 210(4):927–934
Liberman L (2000) Clinical management issues in percutaneous core breast biopsy. Radiol Clin North Am 38(4):791–807
Liberman L et al (1994) Radiography of microcalcifications in stereotaxic mammary core biopsy specimens. Radiology 190(1):223–225
Liberman L et al (2001) Learning curve for stereotactic breast biopsy: how many cases are enough? AJR Am J Roentgenol 176(3):721–727
Liebens F et al (2009) Breast cancer seeding associated with core needle biopsies: a systematic review. Maturitas 62(2):113–123
Meissnitzer et al (2009) Targeted ultrasound of the breast in women with abnormal MRI findings for whom biopsy has been recommended. AJR Am J Roentgenol 193(4):1025–1029. https://doi.org/10.2214/AJR.09.2480
Murphy CD et al (2008) The American Cancer Society guidelines for breast screening with magnetic resonance imaging: an argument for genetic testing. Cancer 113(11):3116–3120
Nyhsen CM et al (2017) Infection prevention and control in ultrasound - best practice recommendations from the European Society of Radiology Ultrasound Working Group. Insights Imaging 8:523–535
Park JM et al (2011) Core biopsy of the breast lesions: review of technical problems and solutions: a pictorial review. Can Assoc Radiol J 62(1):73–82
Park VY et al (2013) Second-look US: how to find breast lesions with a suspicious MR imaging appearance. Radiographics 33(5):1361–1375
Parker SH, Klaus AJ (1997) Performing a breast biopsy with a directional, vacuum-assisted biopsy instrument. Radiographics 17(5):1233–1252
Parker SH et al (1993) US-guided automated large-core breast biopsy. Radiology 187(2):507–511
Patel IJ et al (2012) Consensus guidelines for periprocedural management of coagulation status and hemostasis risk in percutaneous image-guided interventions. J Vasc Interv Radiol 23(6):727–736
Patel IJ et al (2013) Addendum of newer anticoagulants to the SIR consensus guideline. J Vasc Interv Radiol 24(5):641–645
Perry N, Broeders M, de Wolf C, Törnberg S, Holland R, von Karsa L (2006) European guidelines for quality assurance in breast cancer screening and diagnosis, 4th edn. Office for Official Publications of the European Communities, Luxembourg
Perry N et al (2008) European guidelines for quality assurance in breast cancer screening and diagnosis. Fourth edition—summary document. Ann Oncol 19(4):614–622
Peter P et al (2016) MRI screening-detected breast lesions in high-risk young women: the value of targeted second-look ultrasound and imaging-guided biopsy. Clin Radiol 71(10):1037–1043
Plecha DM et al (2014) Addition of shear-wave elastography during second-look MR imaging-directed breast US: effect on lesion detection and biopsy targeting. Radiology 272(3):657–664
Rageth CJ et al (2016) First International Consensus Conference on lesions of uncertain malignant potential in the breast (B3 lesions). Breast Cancer Res Treat 159:203–213
Rageth CJ et al (2019) Second International Consensus Conference on lesions of uncertain malignant potential in the breast (B3 lesions). Breast Cancer Res Treat 174(2):279–296
Riedl CC et al (2005) Potential of dose reduction after marker placement with full-field digital mammography. Invest Radiol 40:343–348
Roberts JG et al (1975) The ‘tru-cut’ biopsy in breast cancer. Clin Oncol 1(4):297–303
Rogers LW (2005) Breast biopsy: a pathologist’s perspective on biopsy acquisition techniques and devices with mammographic–pathologic correlation. Semin Breast Dis 8(3):127–137
Rosen EL et al (2002) Imaging-guided core needle biopsy of papillary lesions of the breast. AJR Am J Roentgenol 179(5):1185–1192
Santiago L et al (2017) Breast cancer neoplastic seeding in the setting of image-guided needle biopsies of the breast. Breast Cancer Res Treat 166(1):29–39
Schueller G et al (2008) US-guided 14-gauge core-needle breast biopsy: results of a validation study in 1352 cases. Radiology 248(2):406–413
Schulz K-D, Kreienberg R, Fischer R, Albert U-S (2003) Stufe-3-Leitlinie Brustkrebs-Früherkennung in Deutschland. Onkologe 9:394–403
Shin JH et al (2007) Targeted ultrasound for MR-detected lesions in breast cancer patients. Korean J Radiol 8(6):475–483
Soo MS, Baker JA, Rosen EL (2003) Sonographic detection and sonographically guided biopsy of breast microcalcifications. AJR Am J Roentgenol 180(4):941–948
Spick C, Baltzer PAT (2014) Diagnostic utility of second-look US for breast lesions identified at MR imaging: systematic review and meta-analysis. Radiology. https://doi.org/10.1148/radiol.14140474
Suh YJ et al (2012) Comparison of the underestimation rate in cases with ductal carcinoma in situ at ultrasound-guided core biopsy: 14-gauge automated core-needle biopsy vs 8- or 11-gauge vacuum-assisted biopsy. Br J Radiol 85(1016):e349–e356
Vosshenrich R, Kühn S, Reimer P (2013) Aufklärung in der Radiologie. Radiologie up2date 13(02):145–155
Wallis M et al (2007) Guidelines from the European Society of Breast Imaging for diagnostic interventional breast procedures. Eur Radiol 17(2):581–588
Wockel A et al (2018) Interdisciplinary screening, diagnosis, therapy and follow-up of breast cancer. Guideline of the DGGG and the DKG (S3-Level, AWMF Registry Number 032/045OL, December 2017) - Part 1 with Recommendations for the screening, diagnosis and therapy of breast cancer. Geburtshilfe Frauenheilkd 78:927–948
Youk JH et al (2008) Sonographically guided 14-gauge core needle biopsy of breast masses: a review of 2,420 cases with long-term follow-up. AJR Am J Roentgenol 190:202–207
Youk JH et al (2010) Analysis of false-negative results after US-guided 14-gauge core needle breast biopsy. Eur Radiol 20(4):782–789
Yu CC et al (2015) Predictors of underestimation of malignancy after image-guided core needle biopsy diagnosis of flat epithelial atypia or atypical ductal hyperplasia. Breast J 21(3):224–232
Zhang C et al (2012) The negative predictive value of ultrasound-guided 14-gauge core needle biopsy of breast masses: a validation study of 339 cases. Cancer Imaging 12:488–496
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Fallenberg, E.M. (2022). Ultrasound-Guided Interventions. In: Fuchsjäger, M., Morris, E., Helbich, T. (eds) Breast Imaging . Medical Radiology(). Springer, Cham. https://doi.org/10.1007/978-3-030-94918-1_8
Download citation
DOI: https://doi.org/10.1007/978-3-030-94918-1_8
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-94917-4
Online ISBN: 978-3-030-94918-1
eBook Packages: MedicineMedicine (R0)